NIH-funded research R21 grant

Understanding how melanoma spreads to the brain

Official title: Metabolic adaptations in melanoma brain metastasis

Funded at New York University School of Medicine · NIH-11002724 · Data updated 2026-11-12

This study is looking into how a specific gene called CNDP1 helps melanoma spread to the brain, with the hope of finding new ways to treat patients who are facing this serious challenge.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2025
Funding year2025
Award (this year)$237,724
NIH project number5R21CA286244-02
Project IDNIH-11002724 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with melanoma who have developed brain metastases.

Less likely to help

Patients with melanoma who do not have brain metastases may not benefit from this research.

What this research studies

This research investigates the mechanisms behind melanoma brain metastasis (MBM), a severe complication of melanoma. By analyzing data from patient samples, the study focuses on a gene called CNDP1, which is found to be elevated in MBM. The researchers will explore how CNDP1 affects the ability of melanoma cells to survive and grow in the brain, using both laboratory and animal models. The goal is to identify new treatment targets that could improve outcomes for patients with this condition.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that specifically target melanoma brain metastasis, improving survival rates and quality of life for affected patients.

How similar studies have gone: Previous research has shown promise in targeting similar pathways in cancer treatment, suggesting potential for success in this approach.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Hernando, Eva — New York University School of Medicine
  • Study coordinator: Hernando, Eva

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.